Your FDA Drug Establishment Registrar
What a drug establishment registrar does, what registration actually involves, and how to choose one that keeps you compliant year after year.
Key Takeaways
- Registration + listing is required — 21 CFR Part 207, before you manufacture or import.
- A registrar manages the full lifecycle — not just the initial filing.
- Registration ≠ approval — it identifies the facility; it doesn't approve the drug.
- Annual renewal (Oct–Dec) — drugs are annual, unlike food's biennial cycle.
- A lapse = misbranding — §502(o), with detention and marketplace removal.
- Choose for responsiveness & continuity — not marketing superlatives.
What a Drug Establishment Registrar Does
Registration isn't a one-and-done form — it's a continuing obligation with several moving parts. A registrar carries the whole lifecycle:
- Establishment registration — the facility filing (21 CFR Part 207) and FEI number
- Drug listing & NDC — listing each product and assigning/maintaining its NDC
- SPL & eDRLS submissions — preparing the electronic filings so they validate against FDA systems
- U.S. Agent — the required domestic contact for foreign establishments
- Annual renewal — tracked and filed each October–December window
- Ongoing updates — listing changes, discontinuations, and FDA communications
Establishments That Must Register
- Finished-drug manufacturers — OTC and prescription
- Active pharmaceutical ingredient (API) manufacturers
- Contract manufacturers (CMOs) — each producing facility registers
- Repackers & relabelers
- Private-label distributors with their own registration obligation
- Foreign establishments — plus a U.S. Agent and known-importer list
Registration ≠ Approval — and Don't Let It Lapse
Registration is not approval. It tells FDA your facility exists and what it makes; it does not evaluate or approve any product. Claiming a drug is "FDA-approved" merely because the establishment is registered or has an NDC is itself misbranding (21 CFR 207.77). Approval is separate — an NDA/ANDA, or OTC monograph compliance.
How to Choose a Drug Establishment Registrar
- Full lifecycle, not a one-time filing — registration, listing/NDC, U.S. Agent, renewal, and updates under one roof
- Responsiveness — FDA questions and border issues move fast; an unreachable registrar is a liability
- Accuracy in eDRLS/SPL — records must validate against FDA systems, or filings stall
- Independence & a real U.S. presence — a partner focused on your compliance, with a physical U.S. address
- Verifiable track record — weigh demonstrable experience over marketing superlatives
Appoint a Full-Service Drug Registrar
FDA Registration Assistance provides fully managed, full-lifecycle drug establishment registration — registration and FEI, listing and NDC via SPL/eDRLS, U.S. Agent, annual renewal, and ongoing maintenance — with responsive support and a physical U.S. presence. We can also take over and correct an existing registration.
Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a scope and quote. An independent compliance firm trusted by 1,000+ companies across 135+ countries, with 15+ years of experience.
Frequently Asked Questions — Drug Establishment Registrar
1. What does a drug establishment registrar do?
A registrar manages the full FDA lifecycle for a drug establishment — not just the initial filing. That includes the establishment registration (21 CFR Part 207) and FEI number, the drug listing and NDC assignment submitted electronically in SPL format (via FDA's eDRLS), the U.S. Agent for foreign facilities, the annual renewal, ongoing listing updates, and handling FDA communications. The point of a registrar is continuity: keeping your registration active and your listings accurate year after year.
2. Who must register a drug establishment with the FDA?
Under Section 510 of the FD&C Act and 21 CFR Part 207: manufacturers of finished drug products (OTC and prescription), active pharmaceutical ingredient (API) manufacturers, contract manufacturers (CMOs), repackers, relabelers, and private-label distributors — both domestic and foreign. If your facility manufactures, prepares, or processes drugs for U.S. commercial distribution, it must register and list its products.
3. Is registration the same as FDA approval?
No — this is the most important thing to understand. Registration (21 CFR Part 207) only tells FDA your facility exists, has an FEI number, and is identified in the supply chain. It is not approval of any product. In fact, claiming a drug is "FDA-approved" merely because the establishment is registered or has an NDC is itself misbranding (21 CFR 207.77). Approval is a separate, product-level status (an NDA/ANDA, or OTC monograph compliance). A prescription drug needs both a registered facility and an approval.
4. What is drug listing and the NDC?
Beyond registering the facility, each drug product must be listed with FDA and assigned a National Drug Code (NDC) — a unique 10-digit identifier. Listing is submitted electronically in Structured Product Labeling (SPL) format, with the labeler code forming the first segment of the NDC. Registration identifies the facility; listing identifies each product it makes. Both must be in place and kept current.
5. What is eDRLS and SPL?
eDRLS is FDA's electronic system for drug registration and listing, and SPL (Structured Product Labeling) is the standardized electronic format those submissions must use. Establishment registration, drug listings, renewals, and updates all flow through this electronic pipeline. A registrar handles the SPL preparation and eDRLS submissions so the records validate correctly against FDA's systems.
6. Do foreign drug manufacturers need a U.S. Agent?
Yes. Foreign drug establishments must designate a U.S. Agent (21 CFR 207.69) as part of registration, and must also identify their known U.S. importers. The U.S. Agent is FDA's domestic point of contact — responding to FDA, helping coordinate inspections, and receiving communications. A registration isn't valid without it, so an active, responsive U.S. Agent is part of a proper registrar service.
7. How often must a drug establishment registration be renewed?
Annually, between October 1 and December 31 (21 CFR 207.29) — drug registration is annual, unlike food facility registration, which is biennial. Drug listings are also reviewed/updated (June and December) as needed. Missing the annual renewal causes the registration to lapse, which makes the establishment's drugs misbranded and subject to detention — so a registrar's deadline tracking is one of the most practical benefits.
8. What happens if my registration lapses?
Drugs from an establishment that isn't currently registered are misbranded under section 502(o) of the FD&C Act. That exposes them to import refusal and detention, FDA warning letters, and removal from marketplaces like Amazon, Walmart, and Shopify, and the associated drug listings can be inactivated. Reactivation takes time during which your products can't move — which is exactly what continuous, managed registration prevents.
9. Can you take over my existing registration from another registrar?
Yes. We can take over an existing FDA drug establishment registration, review it for accuracy, correct any gaps in the registration or listings, and manage it going forward. Companies often switch because their previous registrar was unresponsive, provided only a one-time filing, or didn't handle eDRLS/NDC and renewal maintenance.
10. Do OTC drug companies need to register?
Yes. OTC drug manufacturers must register the establishment and list their products just like prescription-drug makers. The difference is the product pathway: OTC drugs generally rely on compliance with an OTC monograph (rather than an NDA/ANDA) and carry a Drug Facts label. Registration and listing requirements under 21 CFR Part 207 apply the same way.
11. Do contract manufacturers and CMOs need their own registration?
Yes. Every establishment that physically manufactures, repacks, or relabels a drug must maintain its own registration — a contract manufacturer or CMO can't rely solely on the brand owner's registration. The registrant records must reflect the actual establishments involved in producing each listed drug, which is part of accurate listing.
12. Can you manage multiple facilities and drug listings?
Yes. We manage single facilities and multi-establishment, multi-product portfolios — keeping each registration renewed and each listing current across the whole catalog. Consolidating everything under one registrar reduces the risk of a single facility or listing quietly lapsing and taking products offline.
13. Will FDA inspect my drug facility?
It's possible — registration puts your facility in FDA's inspection universe, and drug facilities are subject to cGMP inspections (21 CFR Parts 210 and 211). Keeping registration and listings accurate, and having a responsive U.S. Agent to coordinate, supports inspection readiness. Registration itself doesn't trigger an inspection, but it's the record FDA works from.
14. Is DUNS required for drug establishment registration?
Yes. A DUNS number from Dun & Bradstreet is used to identify the establishment and is required as part of registration; FDA also assigns an FEI (Facility Establishment Identifier). Getting the DUNS and FEI right up front prevents validation errors that can stall the registration or renewal.
15. How do I choose a drug establishment registrar?
Look for full-lifecycle management rather than a one-time filing: registration, listing/NDC via SPL/eDRLS, U.S. Agent, annual renewal tracking, and ongoing updates. Prioritize responsiveness (FDA and border issues move fast), accuracy (records must validate against FDA systems), and independence (a registrar focused on your compliance, not a distributor whose interests may diverge). Verifiable experience and a real physical U.S. presence matter more than marketing superlatives.
16. Why choose FDA Registration Assistance as your registrar?
We provide fully managed, full-lifecycle drug establishment registration — registration and FEI, listing and NDC via SPL/eDRLS, U.S. Agent, annual renewal, and ongoing maintenance — with responsive support and a physical U.S. presence. We're an independent compliance firm (not affiliated with FDA), BBB-accredited, and have supported 1,000+ companies across 135+ countries over 15+ years. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333 for a scope and quote for your establishment.
